Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production.
Immatics to raise $175m in public offering – Pharmaceutical Technology
Share this article Immatics has previously said it projects a cash runway well into 2026. Image credit: Shutterstock/rafapress. NASDAQ-listed Immatics looks set to raise $175m